Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dynamic Medical TechnologiesROCO:4138 +0.94%82 EV-to-EBIT is 7.25 as of Sep. 08, 2026, which is 31% above its 10-year median of 5.52. GuruFocus rates ROCO:4138 with a GF Score™ of 82/100 and a GF Value™ of NT$72.61 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 475 Medical Devices & Instruments companies, Dynamic Medical Technologies ranks better than 84.21% on this metric.
The historical rank and industry rank for Dynamic Medical Technologies's EV-to-EBIT or its related term are showing as below:
ROCO:4138'
s EV-to-EBIT Range Over the Past 10 Years
Min: 2.99 Med: 5.52 Max: 13.95
Current: 7.25
During the past 13 years, the highest EV-to-EBIT of Dynamic Medical Technologies was 13.95. The lowest was 2.99. And the median was 5.52.
ROCO:4138's EV-to-EBIT is ranked better than 84.21% of 475
companies
in the Medical Devices & Instruments industry
Industry Median: 18.49
vs ROCO:4138: 7.25
Dynamic Medical Technologies (ROCO:4138) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Dynamic Medical Technologies's Enterprise Value for the quarter that ended in Jun. 2026 was NT$1,433 Mil.
Dynamic Medical Technologies's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$212 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dynamic Medical Technologies EV-to-EBIT Related Terms
Dynamic Medical Technologies EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Dynamic Medical Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dynamic Medical Technologies EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Dynamic Medical Technologies's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Dynamic Medical Technologies's EV-to-EBIT falls into.
Dynamic Medical Technologies's current Enterprise Value is NT$1,537 Mil.
Dynamic Medical Technologies's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$212 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dynamic Medical Technologies (ROCO:4138) has a EV-to-EBIT of 7.25 as of Sep. 08, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Dynamic Medical Technologies and its competitors. This is 31% above median its historical median of 5.52. Over the past decade, Dynamic Medical Technologies' EV-to-EBIT has ranged from 2.99 to 13.95. According to the industry distribution chart, Dynamic Medical Technologies ranks #75 out of 475 companies in the Medical Devices & Instruments industry, placing it in the top 15.8%.
Is Dynamic Medical Technologies' EV-to-EBIT too high?
Dynamic Medical Technologies' current EV-to-EBIT of 7.25 is 31% above median its 10-year median of 5.52. Over the past 10 years, this metric has ranged from a low of 2.99 to a high of 13.95. The Medical Devices & Instruments industry median EV-to-EBIT is 18.49. Dynamic Medical Technologies' value of 7.25 is 60.8% below this industry median. Based on the distribution chart, Dynamic Medical Technologies ranks #75 out of 475 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Dynamic Medical Technologies has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dynamic Medical Technologies' EV-to-EBIT compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Dynamic Medical Technologies ranks #75 out of 475 companies for EV-to-EBIT. This places Dynamic Medical Technologies in the top 16% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 18.49. Dynamic Medical Technologies' value of 7.25 is 60.8% below this benchmark. Historically, Dynamic Medical Technologies' own EV-to-EBIT has ranged from 2.99 to 13.95 over the past decade. While the company's 10-year median is 5.52 vs. the industry median of 18.49, Dynamic Medical Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.49, based on 475 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dynamic Medical Technologies's current EV-to-EBIT of 7.25 is 60.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Dynamic Medical Technologies and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dynamic Medical Technologies's current EV-to-EBIT is 7.25, which is 31% above median its own 10-year median of 5.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dynamic Medical Technologies stock overvalued right now?
Based on GuruFocus' analysis, Dynamic Medical Technologies (ROCO:4138) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$72.61, compared to a current price of NT$53.60 — trading 26.2% below its estimated fair value. The current EV-to-EBIT is 7.25, which is 31% above median its 10-year median of 5.52 and 60.8% below the Medical Devices & Instruments industry median of 18.49. Dynamic Medical Technologies' overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Dynamic Medical Technologies (ROCO:4138), the current EV-to-EBIT is 7.25 as of Sep. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dynamic Medical Technologies (ROCO:4138) Overvalued in 2026?
Based on GuruFocus' analysis, Dynamic Medical Technologies stock appears to be undervalued.
The current stock price of NT$53.60 is trading 26.2% below its estimated GF Value™ of NT$72.61.
GuruFocus considers Dynamic Medical Technologies to be Modestly Undervalued.
Key valuation signals for ROCO:4138:
EV-to-EBIT: 7.25 (31% above median its 10-year median of 5.52)
GF Value™: NT$72.61 vs. price of NT$53.60 (26.2% below fair value)
Industry Position: 60.8% below the Medical Devices & Instruments median (#75 of 475)
No single metric tells the full story. See the ROCO:4138 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dynamic Medical Technologies Inc is engaged in the sales, maintenance, and integrated marketing of aesthetic lasers and light-based equipment. The company's product line includes aesthetic medical devices, body contouring devices, dermal fillers, and cosmeceuticals. The reportable segments after the adjustment are the Medical equipment trading segment and the Beauty channel segment. The Medical equipment trading segment includes selling, leasing, and repairing medical aesthetic equipment and selling the medical aesthetic consumables and cosmetic products. The Beauty channel segment generates revenues from the sale of lifestyle beauty products and treatments at physical store, as well as the sale of medical aesthetic products.
82GF Score
Get the complete analysis for ROCO:4138
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4138 has been successfully added to your 
